Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Loss of human ICOSL results in combined immunodeficiency.

Roussel L, Landekic M, Golizeh M, Gavino C, Zhong MC, Chen J, Faubert D, Blanchet-Cohen A, Dansereau L, Parent MA, Marin S, Luo J, Le C, Ford BR, Langelier M, King IL, Divangahi M, Foulkes WD, Veillette A, Vinh DC.

J Exp Med. 2018 Dec 3;215(12):3151-3164. doi: 10.1084/jem.20180668.

PMID:
30498080
2.

Developing combination immunotherapies against cancer that make sense.

Veillette A, Davidson D.

Sci Immunol. 2018 Nov 2;3(29). pii: eaav1872. doi: 10.1126/sciimmunol.aav1872. Review.

PMID:
30389799
3.

It takes a village.

Veillette A, Lu Y.

Nat Immunol. 2018 Oct;19(10):1046-1047. doi: 10.1038/s41590-018-0213-0. No abstract available.

PMID:
30224818
4.

Combined mTOR and MEK inhibition is an effective therapy in a novel mouse model for angiosarcoma.

Chadwick ML, Lane A, Thomas D, Smith AR, White AR, Davidson D, Feng Y, Boscolo E, Zheng Y, Adams DM, Gupta A, Veillette A, Chow LML.

Oncotarget. 2018 May 15;9(37):24750-24765. doi: 10.18632/oncotarget.25345. eCollection 2018 May 15.

5.

SIRPα-CD47 Immune Checkpoint Blockade in Anticancer Therapy.

Veillette A, Chen J.

Trends Immunol. 2018 Mar;39(3):173-184. doi: 10.1016/j.it.2017.12.005. Epub 2018 Jan 11. Review.

PMID:
29336991
6.

Two novel mutations in ZAP70 gene that result in human immunodeficiency.

Llamas-Guillén BA, Pastor N, López-Herrera G, González-Serrano ME, Valenzuela-Vázquez L, Bravo-Adame ME, Villanueva-Cabello TM, Gaytán P, Yañez J, Martinez-Duncker I, Ruiz-Fernández M, Veillette A, Espinosa-Padilla SE, Cruz-Munoz ME.

Clin Immunol. 2017 Oct;183:278-284. doi: 10.1016/j.clim.2017.09.005. Epub 2017 Sep 11. No abstract available.

PMID:
28912049
7.

SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin.

Chen J, Zhong MC, Guo H, Davidson D, Mishel S, Lu Y, Rhee I, Pérez-Quintero LA, Zhang S, Cruz-Munoz ME, Wu N, Vinh DC, Sinha M, Calderon V, Lowell CA, Danska JS, Veillette A.

Nature. 2017 Apr 27;544(7651):493-497. doi: 10.1038/nature22076. Epub 2017 Apr 19.

8.

Morpholino-based correction of hypomorphic ZAP70 mutation in an adult with combined immunodeficiency.

Gavino C, Landekic M, Zeng J, Wu N, Jung S, Zhong MC, Cohen-Blanchet A, Langelier M, Neyret O, Lejtenyi D, Rochefort C, Cotton-Montpetit J, McCusker C, Mazer B, Veillette A, Vinh DC.

J Allergy Clin Immunol. 2017 May;139(5):1688-1692.e10. doi: 10.1016/j.jaci.2017.02.002. Epub 2017 Feb 17. No abstract available.

PMID:
28216435
9.

The Csk-Associated Adaptor PAG Inhibits Effector T Cell Activation in Cooperation with Phosphatase PTPN22 and Dok Adaptors.

Davidson D, Zhong MC, Pandolfi PP, Bolland S, Xavier RJ, Seed B, Li X, Gu H, Veillette A.

Cell Rep. 2016 Dec 6;17(10):2776-2788. doi: 10.1016/j.celrep.2016.11.035.

10.

Correction: Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1.

Guo H, Cranert SA, Lu Y, Zhong MC, Zhang S, Chen J, Li R, Mahl SE, Wu N, Davidson D, Waggoner SN, Veillette A.

J Exp Med. 2016 Sep 19;213(10):2227. doi: 10.1084/jem.2016055209072016c. Epub 2016 Sep 12. No abstract available.

11.

Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1.

Guo H, Cranert SA, Lu Y, Zhong MC, Zhang S, Chen J, Li R, Mahl SE, Wu N, Davidson D, Waggoner SN, Veillette A.

J Exp Med. 2016 Sep 19;213(10):2187-207. doi: 10.1084/jem.20160552. Epub 2016 Aug 29. Erratum in: J Exp Med. 2016 Sep 19;213(10):2227.

12.

SLAM-associated protein favors the development of iNKT2 over iNKT17 cells.

Michel ML, Lenoir C, Massot B, Diem S, Pasquier B, Sawa S, Rignault-Bricard R, Lehuen A, Eberl G, Veillette A, Leite-de-Moraes M, Latour S.

Eur J Immunol. 2016 Sep;46(9):2162-74. doi: 10.1002/eji.201646313. Epub 2016 Jul 22.

13.

Activation by SLAM Family Receptors Contributes to NK Cell Mediated "Missing-Self" Recognition.

Alari-Pahissa E, Grandclément C, Jeevan-Raj B, Leclercq G, Veillette A, Held W.

PLoS One. 2016 Apr 7;11(4):e0153236. doi: 10.1371/journal.pone.0153236. eCollection 2016.

14.

A hematopoietic cell-driven mechanism involving SLAMF6 receptor, SAP adaptors and SHP-1 phosphatase regulates NK cell education.

Wu N, Zhong MC, Roncagalli R, Pérez-Quintero LA, Guo H, Zhang Z, Lenoir C, Dong Z, Latour S, Veillette A.

Nat Immunol. 2016 Apr;17(4):387-96. doi: 10.1038/ni.3369. Epub 2016 Feb 15.

PMID:
26878112
15.

SLAM family receptors in normal immunity and immune pathologies.

Wu N, Veillette A.

Curr Opin Immunol. 2016 Feb;38:45-51. doi: 10.1016/j.coi.2015.11.003. Epub 2015 Dec 2. Review.

PMID:
26682762
16.

DNAM-1 controls NK cell activation via an ITT-like motif.

Zhang Z, Wu N, Lu Y, Davidson D, Colonna M, Veillette A.

J Exp Med. 2015 Nov 16;212(12):2165-82. doi: 10.1084/jem.20150792. Epub 2015 Nov 9.

17.

Loss of PTPN12 Stimulates Progression of ErbB2-Dependent Breast Cancer by Enhancing Cell Survival, Migration, and Epithelial-to-Mesenchymal Transition.

Li J, Davidson D, Martins Souza C, Zhong MC, Wu N, Park M, Muller WJ, Veillette A.

Mol Cell Biol. 2015 Dec;35(23):4069-82. doi: 10.1128/MCB.00741-15. Epub 2015 Sep 21.

18.

Mosaic partial deletion of PTPN12 in a child with interrupted aortic arch type A.

Duffy EA, Pretorius PR, Lerach S, Lohr JL, Hirsch B, Souza CM, Veillette A, Schimmenti LA.

Am J Med Genet A. 2015 Nov;167A(11):2674-83. doi: 10.1002/ajmg.a.37279. Epub 2015 Aug 6.

PMID:
26250342
19.

A functional polymorphism of Ptpn22 is associated with type 1 diabetes in the BioBreeding rat.

Sarmiento J, Wallis RH, Ning T, Marandi L, Chao G, Veillette A, Lernmark Å, Paterson AD, Poussier P.

J Immunol. 2015 Jan 15;194(2):615-29. doi: 10.4049/jimmunol.1302689. Epub 2014 Dec 12.

20.

Immune cell inhibition by SLAMF7 is mediated by a mechanism requiring src kinases, CD45, and SHIP-1 that is defective in multiple myeloma cells.

Guo H, Cruz-Munoz ME, Wu N, Robbins M, Veillette A.

Mol Cell Biol. 2015 Jan;35(1):41-51. doi: 10.1128/MCB.01107-14. Epub 2014 Oct 13.

21.

Immunology: When lymphocytes run out of steam.

Veillette A, Davidson D.

Nature. 2014 Jun 12;510(7504):222-3. doi: 10.1038/nature13346. Epub 2014 May 28. No abstract available.

PMID:
24870231
22.

EAT-2, a SAP-like adaptor, controls NK cell activation through phospholipase Cγ, Ca++, and Erk, leading to granule polarization.

Pérez-Quintero LA, Roncagalli R, Guo H, Latour S, Davidson D, Veillette A.

J Exp Med. 2014 Apr 7;211(4):727-42. doi: 10.1084/jem.20132038. Epub 2014 Mar 31.

23.

Control of dendritic cell migration, T cell-dependent immunity, and autoimmunity by protein tyrosine phosphatase PTPN12 expressed in dendritic cells.

Rhee I, Zhong MC, Reizis B, Cheong C, Veillette A.

Mol Cell Biol. 2014 Mar;34(5):888-99. doi: 10.1128/MCB.01369-13. Epub 2013 Dec 23.

24.

Circulating precursor CCR7(lo)PD-1(hi) CXCR5⁺ CD4⁺ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure.

He J, Tsai LM, Leong YA, Hu X, Ma CS, Chevalier N, Sun X, Vandenberg K, Rockman S, Ding Y, Zhu L, Wei W, Wang C, Karnowski A, Belz GT, Ghali JR, Cook MC, Riminton DS, Veillette A, Schwartzberg PL, Mackay F, Brink R, Tangye SG, Vinuesa CG, Mackay CR, Li Z, Yu D.

Immunity. 2013 Oct 17;39(4):770-81. doi: 10.1016/j.immuni.2013.09.007.

25.

X-linked lymphoproliferative syndromes and related autosomal recessive disorders.

Veillette A, Pérez-Quintero LA, Latour S.

Curr Opin Allergy Clin Immunol. 2013 Dec;13(6):614-22. doi: 10.1097/ACI.0000000000000008. Review.

PMID:
24113228
26.

Genome-wide mouse mutagenesis reveals CD45-mediated T cell function as critical in protective immunity to HSV-1.

Caignard G, Leiva-Torres GA, Leney-Greene M, Charbonneau B, Dumaine A, Fodil-Cornu N, Pyzik M, Cingolani P, Schwartzentruber J, Dupaul-Chicoine J, Guo H, Saleh M, Veillette A, Lathrop M, Blanchette M, Majewski J, Pearson A, Vidal SM.

PLoS Pathog. 2013 Sep;9(9):e1003637. doi: 10.1371/journal.ppat.1003637. Epub 2013 Sep 12.

28.

CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myeloma.

Veillette A, Guo H.

Crit Rev Oncol Hematol. 2013 Oct;88(1):168-77. doi: 10.1016/j.critrevonc.2013.04.003. Epub 2013 Jun 2. Review.

PMID:
23731618
29.

Core areas of practice and associated competencies for nurses working as professional cancer navigators.

Cook S, Fillion L, Fitch M, Veillette AM, Matheson T, Aubin M, de Serres M, Doll R, Rainville F.

Can Oncol Nurs J. 2013 Winter;23(1):44-62. English, French.

PMID:
23617218
30.

Macrophage fusion is controlled by the cytoplasmic protein tyrosine phosphatase PTP-PEST/PTPN12.

Rhee I, Davidson D, Souza CM, Vacher J, Veillette A.

Mol Cell Biol. 2013 Jun;33(12):2458-69. doi: 10.1128/MCB.00197-13. Epub 2013 Apr 15.

31.

The adaptor molecule SAP plays essential roles during invariant NKT cell cytotoxicity and lytic synapse formation.

Das R, Bassiri H, Guan P, Wiener S, Banerjee PP, Zhong MC, Veillette A, Orange JS, Nichols KE.

Blood. 2013 Apr 25;121(17):3386-95. doi: 10.1182/blood-2012-11-468868. Epub 2013 Feb 21.

32.

Regulation of the PI3-K/Akt survival pathway in the rat endometrium.

Veillette A, Grenier K, Brasseur K, Fréchette-Frigon G, Leblanc V, Parent S, Asselin E.

Biol Reprod. 2013 Mar 28;88(3):79. doi: 10.1095/biolreprod.112.107136. Print 2013 Mar.

PMID:
23390163
33.

Professional navigation: a comparative study of two Canadian models.

Fillion L, Cook S, Veillette AM, de Serres M, Aubin M, Rainville F, Fitch M, Doll R.

Can Oncol Nurs J. 2012 Autumn;22(4):257-77. English, French.

PMID:
23362659
34.

Critical role of SAP in progression and reactivation but not maintenance of T cell-dependent humoral immunity.

Zhong MC, Veillette A.

Mol Cell Biol. 2013 Mar;33(6):1223-32. doi: 10.1128/MCB.01591-12. Epub 2013 Jan 14.

35.

The phosphatase PTP-PEST/PTPN12 regulates endothelial cell migration and adhesion, but not permeability, and controls vascular development and embryonic viability.

Souza CM, Davidson D, Rhee I, Gratton JP, Davis EC, Veillette A.

J Biol Chem. 2012 Dec 14;287(51):43180-90. doi: 10.1074/jbc.M112.387456. Epub 2012 Oct 26.

36.

Primary T-cell immunodeficiency with immunodysregulation caused by autosomal recessive LCK deficiency.

Hauck F, Randriamampita C, Martin E, Gerart S, Lambert N, Lim A, Soulier J, Maciorowski Z, Touzot F, Moshous D, Quartier P, Heritier S, Blanche S, Rieux-Laucat F, Brousse N, Callebaut I, Veillette A, Hivroz C, Fischer A, Latour S, Picard C.

J Allergy Clin Immunol. 2012 Nov;130(5):1144-1152.e11. doi: 10.1016/j.jaci.2012.07.029. Epub 2012 Sep 15.

PMID:
22985903
37.

The adaptor SAP controls NK cell activation by regulating the enzymes Vav-1 and SHIP-1 and by enhancing conjugates with target cells.

Dong Z, Davidson D, Pérez-Quintero LA, Kurosaki T, Swat W, Veillette A.

Immunity. 2012 Jun 29;36(6):974-85. doi: 10.1016/j.immuni.2012.03.023. Epub 2012 Jun 7.

38.

Protein tyrosine phosphatases in lymphocyte activation and autoimmunity.

Rhee I, Veillette A.

Nat Immunol. 2012 Apr 18;13(5):439-47. doi: 10.1038/ni.2246. Review.

PMID:
22513334
39.

Immunology: Csk keeps LYP on a leash.

Zhong MC, Veillette A.

Nat Chem Biol. 2012 Apr 17;8(5):412-3. doi: 10.1038/nchembio.940. No abstract available.

PMID:
22510660
40.

Redefining interferon-producing killer dendritic cells as a novel intermediate in NK-cell differentiation.

Guimont-Desrochers F, Boucher G, Dong Z, Dupuis M, Veillette A, Lesage S.

Blood. 2012 May 10;119(19):4349-57. doi: 10.1182/blood-2011-11-395954. Epub 2012 Feb 21.

41.

Professional navigation framework: elaboration and validation in a Canadian context.

Fillion L, Cook S, Veillette AM, Aubin M, de Serres M, Rainville F, Fitch M, Doll R.

Oncol Nurs Forum. 2012 Jan;39(1):E58-69. doi: 10.1188/12.ONF.E58-E69.

PMID:
22201669
42.

Immunology: Magnesium in a signalling role.

Wu N, Veillette A.

Nature. 2011 Jul 27;475(7357):462-3. doi: 10.1038/475462a. No abstract available.

PMID:
21796201
43.

La Belle Mort en Milieu Rural: a report of an ethnographic study of the good death for Quebec rural francophones.

Veillette AM, Fillion L, Wilson DM, Thomas R, Dumont S.

J Palliat Care. 2010 Autumn;26(3):159-66.

PMID:
21047038
44.

The phosphatase PTP-PEST promotes secondary T cell responses by dephosphorylating the protein tyrosine kinase Pyk2.

Davidson D, Shi X, Zhong MC, Rhee I, Veillette A.

Immunity. 2010 Aug 27;33(2):167-80. doi: 10.1016/j.immuni.2010.08.001.

45.

Pillars article: the CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. 1994.

Veillette A, Bookman MA, Horak EM, Bolen JB.

J Immunol. 2010 Sep 1;185(5):2650-7. No abstract available.

46.

How do SAP family deficiencies compromise immunity?

Dong Z, Veillette A.

Trends Immunol. 2010 Aug;31(8):295-302. doi: 10.1016/j.it.2010.05.008. Epub 2010 Jul 23. Review.

PMID:
20650688
47.

[The process of integrating oncology nurse navigators into joint (hospital-community) local teams].

Fillion L, Aubin M, de Serres M, Robitaille D, Veillette AM, Rainville F.

Can Oncol Nurs J. 2010 Winter;20(1):30-5. French.

PMID:
20369643
48.

SLAM-family receptors: immune regulators with or without SAP-family adaptors.

Veillette A.

Cold Spring Harb Perspect Biol. 2010 Mar;2(3):a002469. doi: 10.1101/cshperspect.a002469. Review.

49.

Do NK cells always need a license to kill?

Cruz-Munoz ME, Veillette A.

Nat Immunol. 2010 Apr;11(4):279-80. doi: 10.1038/ni0410-279. Review. No abstract available.

PMID:
20300133
50.

Planning and providing for a good death using rural French-Canadian and English-Canadian insights.

Wilson DM, Fillion L, Thomas R, Justice C, Veillette AM, Bhardwaj P.

Rev Neurosci. 2009;20(3-4):313-9.

PMID:
20158002

Supplemental Content

Loading ...
Support Center